View in EDS

Drinkable gene therapy foam for the treatment of constrictive esophageal carcinoma.

Saved in:
Bibliographic Details
Title: Drinkable gene therapy foam for the treatment of constrictive esophageal carcinoma.
Authors: Stephan SB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Cummings CL; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Fitzgerald K; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Stephan MT; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. mstephan@fredhutch.org.; Department of Bioengineering and Molecular Engineering & Sciences Institute, University of Washington, Seattle, WA, USA. mstephan@fredhutch.org.; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. mstephan@fredhutch.org.
Source: Gene therapy [Gene Ther] 2026 Mar; Vol. 33 (2), pp. 118-126. Date of Electronic Publication: 2026 Feb 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5462 (Electronic) Linking ISSN: 09697128 NLM ISO Abbreviation: Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5462
DOI:10.1038/s41434-026-00592-7